| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 151, Issue 7 3407-3419, Copyright © 1993 by American Association of Immunologists
ARTICLES |
KS Anderson, J Alexander, M Wei and P Cresswell
Section of Immunobiology, Howard Hughes Medical Institute, Yale University Medical School, New Haven, CT 06510.
Intracellular transport and stability of class I MHC glycoproteins depends on the assembly of H chain, beta 2-microglobulin, and peptide. The Ag processing mutant cell lines T2 and RMA-S have defects in peptide loading of class I, resulting in reduced cell surface expression of class I molecules. Expression of class I molecules in the murine cell line RMA-S can be induced at 26 degrees C, suggesting that they are transported to the cell surface, but are unstable. However, most human class I molecules in T2 are poorly expressed at the cell surface, even at 26 degrees C. To directly compare the transport of human and mouse alleles in RMA-S and T2, the human alleles HLA-A2, A3, and B27 were transfected into RMA-S along with human beta 2- microglobulin, and the mouse alleles H-2Kb and Db were transfected into T2. Surface expression of HLA-A3 and B27 in RMA-S remained less than 10% of wild-type levels at 26 degrees C. H-2Kb and Db in both cell lines, however, were expressed at 20 to 30% wild-type levels at 37 degrees C and could be induced to wild-type levels at 26 degrees C or with peptides. The selective expression of murine class I glycoproteins at the cell surface of T2 is not because of their greater stability when associated with human beta 2m, since H-2Kb and Db H chain/human beta 2m complexes dissociate more rapidly in vitro than HLA-A3 and B27 complexes. These results suggest that the difference in transport between human and mouse class I in T2 reflects a fundamental structural property of the class I glycoproteins.
This article has been cited by other articles:
|
|
 |
|
  D. R. Peaper and P. Cresswell The redox activity of ERp57 is not essential for its functions in MHC class I peptide loading PNAS, July 29, 2008; 105(30): 10477 - 10482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sibilio, A. Martayan, A. Setini, E. L. Monaco, E. Tremante, R. H. Butler, and P. Giacomini A Single Bottleneck in HLA-C Assembly J. Biol. Chem., January 18, 2008; 283(3): 1267 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Slingluff Jr., G. R. Petroni, K. A. Chianese-Bullock, M. E. Smolkin, S. Hibbitts, C. Murphy, N. Johansen, W. W. Grosh, G. V. Yamshchikov, P. Y. Neese, et al. Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting Clin. Cancer Res., November 1, 2007; 13(21): 6386 - 6395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Garstka, B. Borchert, M. Al-Balushi, P. Praveen, N. Kuhl, I. Majoul, R. Duden, and S. Springer Peptide-receptive Major Histocompatibility Complex Class I Molecules Cycle between Endoplasmic Reticulum and cis-Golgi in Wild-type Lymphocytes J. Biol. Chem., October 19, 2007; 282(42): 30680 - 30690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yokokawa, C. Palena, P. Arlen, R. Hassan, M. Ho, I. Pastan, J. Schlom, and K. Y. Tsang Identification of Novel Human CTL Epitopes and Their Agonist Epitopes of Mesothelin Clin. Cancer Res., September 1, 2005; 11(17): 6342 - 6351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Mosquera, K. F. Card, S. A. Price-Schiavi, H. J. Belmont, B. Liu, J. Builes, X. Zhu, P.-A. Chavaillaz, H.-i. Lee, J.-a. Jiao, et al. In Vitro and In Vivo Characterization of a Novel Antibody-Like Single-Chain TCR Human IgG1 Fusion Protein J. Immunol., April 1, 2005; 174(7): 4381 - 4388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Chianese-Bullock, J. Pressley, C. Garbee, S. Hibbitts, C. Murphy, G. Yamshchikov, G. R. Petroni, E. A. Bissonette, P. Y. Neese, W. W. Grosh, et al. MAGE-A1-, MAGE-A10-, and gp100-Derived Peptides Are Immunogenic When Combined with Granulocyte-Macrophage Colony-Stimulating Factor and Montanide ISA-51 Adjuvant and Administered as Part of a Multipeptide Vaccine for Melanoma J. Immunol., March 1, 2005; 174(5): 3080 - 3086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Y. Tsang, C. Palena, J. Yokokawa, P. M. Arlen, J. L. Gulley, G. P. Mazzara, L. Gritz, A. Gomez Yafal, S. Ogueta, P. Greenhalgh, et al. Analyses of Recombinant Vaccinia and Fowlpox Vaccine Vectors Expressing Transgenes for Two Human Tumor Antigens and Three Human Costimulatory Molecules Clin. Cancer Res., February 15, 2005; 11(4): 1597 - 1607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Slingluff Jr, G. R. Petroni, G. V. Yamshchikov, S. Hibbitts, W. W. Grosh, K. A. Chianese-Bullock, E. A. Bissonette, D. L. Barnd, D. H. Deacon, J. W. Patterson, et al. Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed Schedule J. Clin. Oncol., November 15, 2004; 22(22): 4474 - 4485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Thomas, L. M. Santarsiero, E. R. Lutz, T. D. Armstrong, Y.-C. Chen, L.-Q. Huang, D. A. Laheru, M. Goggins, R. H. Hruban, and E. M. Jaffee Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients J. Exp. Med., August 2, 2004; 200(3): 297 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-Y. Tsang, C. Palena, J. Gulley, P. Arlen, and J. Schlom A Human Cytotoxic T-Lymphocyte Epitope and Its Agonist Epitope from the Nonvariable Number of Tandem Repeat Sequence of MUC-1 Clin. Cancer Res., March 15, 2004; 10(6): 2139 - 2149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Astsaturov, T. Petrella, E. U. Bagriacik, M. de Benedette, R. Uger, G. Lumber, N. Berinstein, I. Elias, N. Iscoe, C. Hammond, et al. Amplification of Virus-Induced Antimelanoma T-Cell Reactivity by High-Dose Interferon-{alpha}2b: Implications for Cancer Vaccines Clin. Cancer Res., October 1, 2003; 9(12): 4347 - 4355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Boyle and J. S. Hill Gaston Breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies Rheumatology, March 1, 2003; 42(3): 404 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Hill, T. Kasliwal, E. Schwarz, A. M. Hebert, T. Chen, E. Gubina, L. Zhang, and S. Kozlowski A Dominant Negative Mutant beta 2-Microglobulin Blocks the Extracellular Folding of a Major Histocompatibility Complex Class I Heavy Chain J. Biol. Chem., February 14, 2003; 278(8): 5630 - 5638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Terasawa, K.-Y. Tsang, J. Gulley, P. Arlen, and J. Schlom Identification and Characterization of a Human Agonist Cytotoxic T-Lymphocyte Epitope of Human Prostate-specific Antigen Clin. Cancer Res., January 1, 2002; 8(1): 41 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Vonderheide, K. S. Anderson, W. C. Hahn, M. O. Butler, J. L. Schultze, and L. M. Nadler Characterization of HLA-A3-restricted Cytotoxic T Lymphocytes Reactive against the Widely Expressed Tumor Antigen Telomerase Clin. Cancer Res., November 1, 2001; 7(11): 3343 - 3348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Boyle, J. C. Goodall, S. S. Opat, and J. S. H. Gaston The Recognition of HLA-B27 by Human CD4+ T Lymphocytes J. Immunol., September 1, 2001; 167(5): 2619 - 2624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Esser, J. W. Bess Jr., K. Suryanarayana, E. Chertova, D. Marti, M. Carrington, L. O. Arthur, and J. D. Lifson Partial Activation and Induction of Apoptosis in CD4+ and CD8+ T Lymphocytes by Conformationally Authentic Noninfectious Human Immunodeficiency Virus Type 1 J. Virol., February 1, 2001; 75(3): 1152 - 1164. [Abstract] [Full Text]
|
|
|
|
|
|
F. Gays, K. P. Fraser, J. A. Toomey, A. G. Diamond, M. M. Millrain, P. J. Dyson, and C. G. Brooks Functional Analysis of the Molecular Factors Controlling Qa1-Mediated Protection of Target Cells from NK Lysis J. Immunol., February 1, 2001; 166(3): 1601 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. B. Myers, M. R. Harris, J. M. Connolly, L. Lybarger, Y. Y. L. Yu, and T. H. Hansen Kb, Kd, and Ld Molecules Share Common Tapasin Dependencies as Determined Using a Novel Epitope Tag J. Immunol., November 15, 2000; 165(10): 5656 - 5663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Barnden, A. W. Purcell, J. J. Gorman, and J. McCluskey Tapasin-Mediated Retention and Optimization of Peptide Ligands During the Assembly of Class I Molecules J. Immunol., July 1, 2000; 165(1): 322 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lauvau, B. Gubler, H. Cohen, S. Daniel, S. Caillat-Zucman, and P. M. van Endert Tapasin Enhances Assembly of Transporters Associated with Antigen Processing-dependent and -independent Peptides with HLA-A2 and HLA-B27 Expressed in Insect Cells J. Biol. Chem., October 29, 1999; 274(44): 31349 - 31358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. De Silva, A. Boesteanu, R. Song, N. Nagy, E. Harhaj, C. V. Harding, and S. Joyce Thermolabile H-2Kb Molecules Expressed by Transporter Associated with Antigen Processing-Deficient RMA-S Cells Are Occupied by Low-Affinity Peptides J. Immunol., October 15, 1999; 163(8): 4413 - 4420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Brooks, F. Borrego, P. E. Posch, A. Patamawenu, C. J. Scorzelli, M. Ulbrecht, E. H. Weiss, and J. E. Coligan Specific Recognition of HLA-E, But Not Classical, HLA Class I Molecules by Soluble CD94/NKG2A and NK Cells J. Immunol., January 1, 1999; 162(1): 305 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Blaney Jr., E. Nobusawa, M. A. Brehm, R. H. Bonneau, L. M. Mylin, T.-M. Fu, Y. Kawaoka, and S. S. Tevethia Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity J. Virol., December 1, 1998; 72(12): 9567 - 9574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Shields, R. Kubota, W. Hodgson, S. Jacobson, W. E. Biddison, and R. K. Ribaudo The Effect of Human beta 2-Microglobulin on Major Histocompatibility Complex I Peptide Loading and the Engineering of a High Affinity Variant. IMPLICATIONS FOR PEPTIDE-BASED VACCINES J. Biol. Chem., October 23, 1998; 273(43): 28010 - 28018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Correale, K. Walmsley, S. Zaremba, M. Zhu, J. Schlom, and K. Y. Tsang Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide J. Immunol., September 15, 1998; 161(6): 3186 - 3194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shi, K. D. Smith, and C. T. Lutz TAP-Independent MHC Class I Peptide Antigen Presentation to Alloreactive CTL Is Enhanced by Target Cell Incubation at Subphysiologic Temperatures J. Immunol., May 1, 1998; 160(9): 4305 - 4312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Shields, N. Assefi, W. Hodgson, E. J. Kim, and R. K. Ribaudo Characterization of the Interactions Between MHC Class I Subunits: A Systematic Approach for the Engineering of Higher Affinity Variants of {beta}2-Microglobulin J. Immunol., March 1, 1998; 160(5): 2297 - 2307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-M. Fu, L. M. Mylin, T. D. Schell, I. Bacik, G. Russ, J. W. Yewdell, J. R. Bennink, and S. S. Tevethia An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope J. Virol., February 1, 1998; 72(2): 1469 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Suzue, X. Zhou, H. N. Eisen, and R. A. Young Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway PNAS, November 25, 1997; 94(24): 13146 - 13151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rajagopalan and E. O. Long The Direct Binding of a p58 Killer Cell Inhibitory Receptor to Human Histocompatibility Leukocyte Antigen (HLA)-Cw4 Exhibits Peptide Selectivity J. Exp. Med., April 21, 1997; 185(8): 1523 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Malnati, M Peruzzi, K. Parker, W. Biddison, E Ciccone, A Moretta, and E. Long Peptide specificity in the recognition of MHC class I by natural killer cell clones Science, February 17, 1995; 267(5200): 1016 - 1018. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
